Myomo (MYO) Profit After Tax Growth (1y) (2017 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | -18.72% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 13.91% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | -12.28% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 99.26% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 4.70% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 125.69% |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 89.28% |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | -27.13% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 51.30% |
| 10 | Myomo | 44.63 Mn | 26.23 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -279.02% |
| Jun 30, 2025 | -312.98% |
| Mar 31, 2025 | 9.66% |
| Dec 31, 2024 | 89.43% |
| Sep 30, 2024 | 52.37% |
| Jun 30, 2024 | -10.60% |
| Mar 31, 2024 | -45.05% |
| Dec 31, 2023 | -13.50% |
| Sep 30, 2023 | 28.30% |
| Jun 30, 2023 | 65.14% |
| Mar 31, 2023 | 6.06% |
| Dec 31, 2022 | 20.70% |
| Sep 30, 2022 | -37.56% |
| Jun 30, 2022 | -10.97% |
| Mar 31, 2022 | 4.93% |
| Dec 31, 2021 | -60.93% |
| Sep 30, 2021 | 25.92% |
| Jun 30, 2021 | 20.25% |
| Mar 31, 2021 | 22.13% |
| Dec 31, 2020 | 38.50% |
| Sep 30, 2020 | 0.41% |
| Jun 30, 2020 | -28.13% |
| Mar 31, 2020 | -46.34% |
| Dec 31, 2019 | -2.58% |
| Sep 30, 2019 | -5.22% |
| Jun 30, 2019 | 2.44% |
| Mar 31, 2019 | -10.77% |
| Dec 31, 2018 | -41.66% |
| Sep 30, 2018 | -110.48% |
| Jun 30, 2018 | 64.38% |
| Mar 31, 2018 | -50.69% |
| Dec 31, 2017 | -56.88% |
| Sep 30, 2017 | -23.64% |
| Jun 30, 2017 | -871.44% |